Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer and EVP
-
Stock Symbol
-
MCRB on Nasdaq
Matthew R. Henn - trading volume in the past year for Seres Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
77.8K |
$42.1K |
$0.54 |
Nov 18, 2024 |
Direct |
|
|
| Restricted Stock Units |
25.3K |
$17.5K |
$0.69 |
Nov 15, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
288K |
|
|
Feb 14, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.